Sign In
Buy LLY
$1,125.38
+42.15 (+3.89%)
At Close: Jun 04, 2026
10 Biggest Companies Reporting Earnings in the First Week of Feb 2023
10:56pm, Wednesday, 25'th Jan 2023
The fourth quarter earnings season for the S&P 500 didn't get off to a strong start.
2 Ultra-Safe Dividend Stocks to Own in 2023
02:30pm, Wednesday, 25'th Jan 2023 The Motley Fool
These two top dividend stocks won't keep you up at night.
Eli Lilly: Far From Dead In Alzheimer's, But Needs Help From Other Areas
02:12pm, Wednesday, 25'th Jan 2023
The recent FDA complete response letter to Eli Lilly and Company about donanemab was inevitable. Approval of donanemab remains uncertain.
Should You Invest in the Fidelity MSCI Health Care Index ETF (FHLC)?
11:20am, Wednesday, 25'th Jan 2023 Zacks Investment Research
Sector ETF report for FHLC
Is Biogen Stock a No-Brainer Buy After Eli Lilly's Alzheimer's Disease Setback?
10:57am, Wednesday, 25'th Jan 2023 The Motley Fool
Lilly's FDA rejection puts Biogen and its partner Eisai in the driver's seat in the Alzheimer's disease drug market.
Eli Lilly (LLY) Gains As Market Dips: What You Should Know
10:45pm, Tuesday, 24'th Jan 2023 Zacks Investment Research
Eli Lilly (LLY) closed at $346.39 in the latest trading session, marking a +1.22% move from the prior day.
Brokers Suggest Investing in Lilly (LLY): Read This Before Placing a Bet
02:30pm, Tuesday, 24'th Jan 2023 Zacks Investment Research
According to the average brokerage recommendation (ABR), one should invest in Lilly (LLY). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommenda
Eli Lilly to invest additional $450 million in Research Triangle Park facility, to add at least 100 jobs
06:42am, Tuesday, 24'th Jan 2023
Eli Lilly & Co. LLY, -1.12% said Tuesday it's planning to invest an additional $450 million in a manufacturing site at Research Triangle Park in North Carolina and will create at least 100 jobs. The n
Jim Cramer says there's a buying opportunity in this pharmaceutical company
07:55pm, Monday, 23'rd Jan 2023
Cramer gave his take on why investors should consider picking up shares of Eli Lilly.
Lilly (LLY) Jardiance Kidney Disease sNDA Gets FDA Acceptance
03:38pm, Monday, 23'rd Jan 2023 Zacks Investment Research
Eli Lilly's (LLY) sNDA seeks approval for diabetes medicine, Jardiance, to reduce the risk of kidney disease progression and cardiovascular death in adults with CKD.
Concert (CNCE) Stock Up 17% Last Week on Sun Pharma Buyout Offer
02:38pm, Monday, 23'rd Jan 2023 Zacks Investment Research
Concert Pharmaceuticals (CNCE) enters into a definitive agreement to be acquired by India-based Sun Pharmaceutical for $576 million. Stock up 17% in the previous week.
Lilly (LLY) Jardiance Kidney Disease sNDA Gets FDA Acceptance
12:03pm, Monday, 23'rd Jan 2023
Eli Lilly's (LLY) sNDA seeks approval for diabetes medicine, Jardiance, to reduce the risk of kidney disease progression and cardiovascular death in adults with CKD.
3 Drug Stocks With Promising Pipelines for 2023
10:03am, Monday, 23'rd Jan 2023
The world of pharmaceutical progress happens incrementally and exponentially. That is, therapies are iteratively improved while breakthrough treatments are also created and discovered.
Lilly's Alzheimer's drug setback is ‘not a thesis-breaker'
02:44pm, Saturday, 21'st Jan 2023
Eli Lilly & Co (NYSE: LLY) ended slightly down on Friday after the U.S. FDA rejected its request of accelerated approval for Donanemab – its Alzheimer's drug. Why did the FDA reject its application?
Why the FDA didn't grant an approval to Lilly's Alzheimer's drug
02:19pm, Saturday, 21'st Jan 2023 MarketWatch
The regulator wants to see clinical data from at least 100 patients who have taken donanemab for a year
